The legal battles over Ozempics side effects bring to light critical questions about drug safety, transparency, and the responsibilities of pharmaceutical giants like Novo Nordisk
Implications for employers: This study provides evidence that pharmaceutical manufacturers could make substantial profits selling these drugs at much lower costs in the US
Case 2: Seeing visceral fat directly on CT Another patient with CT-detected coronary atherosclerosis and a raised fat attenuation index (FAI) a marker of coronary inflammation showed a glucose profile on CGM very similar to the first case
So pay attention when designing them
High-dose semaglutide (up to 16 mg) in people with type 2 diabetes and overweight or obesity: a randomized, placebo-controlled, phase 2 trial
Goal: metabolic health improvement without maximum weight loss Some researchers are primarily interested in retatrutide for metabolic health markers: insulin sensitivity, liver fat reduction, lipid profiles, and inflammatory markers